SOD1 and amyotrophic lateral sclerosis: The human SOD1 gene with the G93A point mutation (alanine substitution for glycine at position 93) was the first experimental molecular defect to result in a progressive paralytic disease in transgenic mice with clinical features similar to human ALS [5].